| Dokumendiregister | Ravimiamet |
| Viit | REP-1/1808-1 |
| Registreeritud | 17.05.2024 |
| Sünkroonitud | 20.05.2024 |
| Liik | Sissetulev kiri |
| Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
| Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
| Toimik | REP-1/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Signe Leito (RA, Labor) |
| Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 10. aprill 2024 13:39 Adressaat: Signe Leito Teema: Proposed addition to the work programme P4: Vismodegib and Vismodegib capsules: EDQM-2024-01508-mail
Please make sure to include in any reply our mail reference: EDQM-2024-01508-mail **************************************************************************** For the attention of: NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of two monographs to the work programme of Group P4: https://survey.edqm.eu/index.php?r=survey/index&sid=187384&newtest=Y&lang=en - Vismodegib - Vismodegib capsules Deadline for replies: 20 May 2024 With kind regards, On behalf of Monica Sorinas Jimeno Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2024-01508-mail
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|